BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 7145726)

  • 1. Placental protein 5 (PP5)-like immunoreactivity in human urine.
    Siiteri JE; Koistinen R; Bohn H; Seppälä M
    Oncodev Biol Med; 1982; 3(5-6):403-7. PubMed ID: 7145726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human seminal plasma contains a protein that shares physicochemical and immunochemical properties with placental protein 5 from the human placenta.
    Ranta T; Siiteri JE; Koistinen R; Salem HT; Bohn H; Koskimies AI; Seppälä M
    J Clin Endocrinol Metab; 1981 Nov; 53(5):1087-9. PubMed ID: 7287877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Placental protein 5 (PP5) in pregnancy and malignant disease: the influence of heparin binding.
    Nisbet AD; Brenner RD; Horne CH; Bohn H
    Clin Chim Acta; 1982 Feb; 119(1-2):21-9. PubMed ID: 7060273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperstimulated human preovulatory follicular fluid contains placental protein 5 (PP5).
    Seppälä M; Tenhunen A; Koskimies AI; Wahlström T; Koistinen R; Stenman UH
    Fertil Steril; 1984 Jan; 41(1):62-5. PubMed ID: 6420205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human endometrium and menstrual fluid contain placental protein 5 (PP5).
    Bützow R; Alfthan H; Julkunen M; Rutanen EM; Bohn H; Seppälä M
    Hum Reprod; 1986 Aug; 1(5):287-9. PubMed ID: 3558771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibodies reacting with placental protein 5: use in radioimmunoassay, Western blot analysis, and immunohistochemistry.
    Bützow R; Virtanen I; Seppälä M; Närvänen O; Stenman UH; Ristimäki A; Bohn H
    J Lab Clin Med; 1988 Feb; 111(2):249-56. PubMed ID: 3276802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular heterogeneity of placental protein 5 (PP5) in late pregnancy serum and plasma: evidence for a heparin-PP5 polymer.
    Salem HT; Obiekwe BC; Al-Ani AT; Seppälä M; Chard T
    Clin Chim Acta; 1980 Nov; 107(3):211-5. PubMed ID: 7438456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of placental protein 5 (PP5) by non-malignant human fibroblasts in culture. Comparison with 'pregnancy-specific' glycoprotein (SP1).
    Nisbet AD; Rosen SW; Ellmore N; Bremner RD; Horne CH
    Oncodev Biol Med; 1983; 4(4):281-8. PubMed ID: 6601264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The human fallopian tube contains placental protein 5.
    Bützow R
    Hum Reprod; 1989 Jan; 4(1):17-20. PubMed ID: 2651471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification of high molecular weight urokinase from human urine and comparative study of two active forms of urokinase.
    Shibatani T; Kakimoto T; Chibata I
    Thromb Haemost; 1983 Apr; 49(2):91-5. PubMed ID: 6346574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory properties of a novel human Kunitz-type protease inhibitor homologous to tissue factor pathway inhibitor.
    Petersen LC; Sprecher CA; Foster DC; Blumberg H; Hamamoto T; Kisiel W
    Biochemistry; 1996 Jan; 35(1):266-72. PubMed ID: 8555184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of placental protein five (PP5) and pregnancy-specific glycoprotein (SP1) in benign and malignant breast disease.
    Bremner RD; Nisbet AD; Herriot R; Horne CH; McArdle C; Crawford D; Bohn H
    Oncodev Biol Med; 1981; 2(1-2):55-62. PubMed ID: 6975467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of radioimmunoassays for high- and low-molecular weight urokinases and estimation of different molecular forms of urokinase in urine and plasma.
    Cheung T; Lui AY; Lau HK
    J Lab Clin Med; 1993 Mar; 121(3):461-71. PubMed ID: 8445294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a specific anti-human urokinase antibody: development of a sensitive competition radioimmunoassay for urokinase antigen.
    Huber K; Kirchheimer J; Binder BR
    J Lab Clin Med; 1984 May; 103(5):684-94. PubMed ID: 6715950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subcellular localization of PP5/TFPI-2 in human placenta: a possible role of PP5/TFPI-2 as an anti-coagulant on the surface of syncytiotrophoblasts.
    Udagawa K; Yasumitsu H; Esaki M; Sawada H; Nagashima Y; Aoki I; Jin M; Miyagi E; Nakazawa T; Hirahara F; Miyazaki K; Miyagi Y
    Placenta; 2002; 23(2-3):145-53. PubMed ID: 11945080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid isolation of high molecular weight urokinase from native human urine.
    Huber K; Kirchheimer J; Binder BR
    Thromb Haemost; 1982 Jun; 47(3):197-202. PubMed ID: 7051408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation of a novel glycoprotein (EDC1) from the urine of a patient with acute myelocytic leukemia.
    Rudman D; Chawla RK; Hendrickson LJ; Vogler WR; Sophianopoulos AJ
    Cancer Res; 1976 May; 36(5):1837-46. PubMed ID: 57827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of pergonal on in vitro production of placental protein 5 (PP5) by ovarian tumour cells.
    Sinosich MJ; Dodd J; Hudson CN; Tyler JR; Seppala M; Grudzinskas JG; Saunders DM
    Tumour Biol; 1985; 6(3):233-42. PubMed ID: 2416032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of thrombin on serum placental protein 5 (PP5): is PP5 the naturally occurring antithrombin III of the human placenta?
    Salem HT; Seppälä M; Chard T
    Placenta; 1981; 2(3):205-9. PubMed ID: 7279875
    [No Abstract]   [Full Text] [Related]  

  • 20. Placental protein 5 (PP5): development of a radioimmunoassay and measurement of circulating levels in normal pregnancy.
    Nisbet AD; Bremner RD; Herriot R; Jandial V; Horne CH; Bohn H
    Br J Obstet Gynaecol; 1981 May; 88(5):484-91. PubMed ID: 7195276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.